Overweight and obesity influence contraceptive choice
Dr Annabel Forsythe and Valerie Warner Findlay explore the latest recommendations from the FSRH about contraceptive use in women who are overweight or obese
Top tips: talking about weight
Jane Diggle and Dr Pam Brown offer 10 top tips on initiating conversations about weight and motivating people to make healthy changes
GPs need to signpost children with obesity to good local services
Professor Julian Hamilton-Shield explains the thinking behind the NICE quality standard on prevention and lifestyle weight management in children and young people with obesity
Test and reflect
Educational resources
Formulary decision guide: Saxenda® (liraglutide injection 3 mg)
This formulary decision guide has been commissioned by Novo Nordisk. Information intended for UK healthcare professionlas only.
Click here for the Prescribing Information and Adverse Events Reporting.
UK20SX00110
Date of preparation: October 2020